“did not reach statistical significance”

Although the between-group difference for the Stroop effect did not reach statistical significance at p < 0.05 using non-parametric analyses (Table 2 ), given the small sample sizes the difference between the groups’ Stroop effect was further considered by examining the effect size [ 48 ] for the between-group comparison.

Despite the higher hazard ratios, they did not reach statistical significance (p < 0.05).

30%) did not reach statistical significance (p < 0.05; chi-square and Fisher exact test), the relative risk and odds ratio for death were 1.83 and 2.85 times higher in open abdomen patients group.

Osteopontin expression remained associated with RFS when corrected for age, sex and tumour site ( P =0.006), but after adjusting additionally for SNB status did not reach statistical significance at the P =0.05 level ( P =0.07).

1A ), while the difference for T2R patients and matched controls did not reach statistical significance (P = 0.05) (Fig. 2A ).

For VAT, similar results were obtained ( P < 0.0001 for women and P = 0.0006 for men), although the sex interaction did not reach statistical significance ( P = 0.05).

Although the effects of age and gender independently did not reach statistical significance in the likelihood of job change, the interaction between these two variables did show a significant effect (F = 3.376; p < 0.05), indicating, for instance, that younger men may be particularly prone to job changes in the short term, while older women are more likely to remain in their current roles.

Although the reduction in ASS did not reach statistical significance ( p = 0.05), the observed difference between the PER and LEV groups suggests a potential clinical benefit worthy of further study.

Additionally, and although the associations did not reach statistical significance at the 1% level, patients with lung cancer tended to report poorer SF-36 Physical Functioning than patients with either ovarian cancer or multiple myeloma ( P <0.05), poorer SF-36 Role Physical scores than patients with either breast and ovarian cancer ( P <0.05), and poorer FACT non-fatigue scores than patients with all other cancers ( P <0.10).

Quantitative analysis identified a trend towards fewer TrkB expressing cells in the Dlx1/Dlx2 mutants ( Figure 6 A), although the differences in TrkB+ cells did not reach statistical significance ( T = 2.78, P = 0.05, N = 5).

Serum CC16 levels were inversely related to urinary As concentrations ( r = −0.11, p = 0.07), although the association did not reach statistical significance at p < 0.05 among all individuals.

Across all three datasets, higher levels of the NFκB and AP-1 upregulated genes were generally associated with worse outcome although the outcome differences between the high/low dichotomized cases often did not reach statistical significance (p < 0.05).

Specifically, in the DRF < 40% group, the difference between preoperative and postoperative measurements did not reach statistical significance ( p = 0.050).

271.1 min, p = 0.63); however, blood loss appeared to be higher in the hand‐sewn group compared to the stapled group, though the difference did not reach statistical significance (61.1 vs. 37.5 mL, p = 0.05).

Moreover, in chicken BMSCs, miR-26a-5p overexpression statistically decreased MDFIC mRNA levels ( P < 0.05), whereas miR-26a-5p inhibition showed an increasing trend that did not reach statistical significance ( P > 0.05; Fig. 6 C,D).

Although downward trends with advancing age were observed for SOD1, SOD2, PRDX1, and SRXN1, these changes did not reach statistical significance, except for SOD2 in the 50–59 age group and SRXN1 in the 60–69 age group ( p < 0.05, Figure S2 ).

Although BDNF levels showed an increasing trend in the DLT-treated group, this change did not reach statistical significance ( p > 0.05; Fig. 2 E, F).

Later age of symptom onset (70+ years) was associated with lower odds of genetic testing completion (OR 0.23; 95% CI 0.12–0.43; P < 0.001) compared to the reference group (10–19 years), while early symptom onset (0–9 years) showed a trend toward higher odds of genetic testing completion that approached but did not reach statistical significance (OR 1.53; 95% CI 1–2.37; P = 0.05).

However, the overall value did not reach statistical significance ( p = 0.05).

However, in WT KRAS IHC‐positive samples we also observed difference between N cry and T2 ( p = 0.022) and a trend towards difference in staining intensity between the T1 and the T2; however, this did not reach statistical significance ( p = 0.050; Table 1 ).

Overall, although postoperative Qmax and IPSS showed a trend toward better outcomes in the F21 group, these differences did not reach statistical significance ( p > 0.05).

Among patients with infection, PSP levels were higher in culture-positive compared to culture-negative patients, but the difference did not reach statistical significance (median 229 vs. 142 ng/ml, p = 0.05).

In the initial univariate analysis, clinical parameters such as antibiotic exposure and clinical signs did not reach statistical significance (P < 0.05) and were therefore excluded from the final multivariate regression model.

Peak diastolic arterial blood pressure did not reach statistical significance between groups (interaction effect: p = 0.050, ISC: 95 ± 5 vs. 103 ± 12 mmHg, CON: 100 ± 12 vs. 97 ± 1 mmHg).

For the KOOS Activities of Daily Living domain, the intraosseous PRGF group also demonstrated significantly better results at 6 months ( p = 0.007) and 12 months ( p = 0.002), though the difference at 3 months did not reach statistical significance ( p = 0.050). 3.3.